ClinicalTrials.gg
Status unknownNCT04554407Updated Sep 28, 2021

Study to Evaluate the Performance of a Sustained Vacuum System

An interventional study of SOMAVAC® 100 Sustained Vacuum System in Seroma as Procedural Complication and Hematoma Postoperative, sponsored by SOMAVAC Medical Solutions. Status unknown at 1 site in United States. Open to female participants aged 21 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-09-28.

Sponsored by SOMAVAC Medical Solutions · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Sep 2020), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
29
Allocation
Not applicable
Ages
21 Years and older
Sex
Female
01

Study summary

The purpose of this study is to evaluate the performance of the SOMAVAC® 100 Sustained Vacuum System after oncologic resections.

02

Conditions studied

  • Seroma as Procedural Complication
  • Hematoma Postoperative

Browse trials for

Keywords

  • Seroma Following Procedure
  • Healing Delayed
  • Dehiscence
03

In context

Hematoma

109 studies on the registry are indexed under Hematoma; 19 are open to participants now.

This study's enrollment of 29 is below the median of 107 across 83 interventional studies indexed under Hematoma.

Browse Hematoma studies →

Lead sponsor

This is the only study on the registry with SOMAVAC Medical Solutions as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 21 years or older;
  • Undergoing mastectomy (uni or bilateral), axillary node resection, or inguinal node resection;
  • Capable of providing .

Exclusion criteria

Exclusion Criteria:

  • Pregnant or lactating females;
  • Patients on or other immune modulators known to impact healing;
  • Patients who are likely to not complete the study;
  • Patients who, in the opinion of the investigator, are unlikely to comply with the protocol;
  • Patients who have participated in this trial previously and who were withdrawn;
  • Patients with known allergies to contacting materials (i.e. latex, metal, etc.);
  • Patients who received chemotherapy or radiotherapy within the last 3 weeks.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Adjuvant and neoadjuvant

Neoadjuvant treatment is given before the main treatment (usually surgery), often to shrink a tumour. Adjuvant treatment is given after it, to lower the chance of the cancer coming back.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
29 participants (actual)

Study arms

  • Experimental
    Treatment Group

    All participants receive the SOMAVAC® 100 Sustained Vacuum System

    Device: SOMAVAC® 100 Sustained Vacuum System

Interventions

  • DeviceSOMAVAC® 100 Sustained Vacuum System

    The SOMAVAC® 100 is a battery operated device that delivers 100mm/Hg of continuous suction.

06

What researchers measure

Primary outcomes

  1. Time with drains

    Determine the length of time drains were used

    Time frame: 1 - 6 weeks

  2. Surgical site related complications

    Evaluate the number of surgical site related complication

    Time frame: 1 week - 1 year

Secondary outcomes

  1. Patient reported usability of the suction device

    Determine patient reported usability of the suction device with the system usability scale

    Time frame: 1week - 1year

  2. Amount of fluid collected

    Determine the total amount of fluid collected

    Time frame: 1week - 6 weeks

07

Study locations

1 site
  • University of Tennessee Heath Science Center
    Memphis, Tennessee 38106, United States
08

References and documents

Publications

  • Agrawal A, Ayantunde AA, Cheung KL. Concepts of seroma formation and prevention in breast cancer surgery. ANZ J Surg. 2006 Dec;76(12):1088-95. doi: 10.1111/j.1445-2197.2006.03949.x. PubMed 17199696 ↗
  • Carruthers KH, Eisemann BS, Lamp S, Kocak E. Optimizing the closed suction surgical drainage system. Plast Surg Nurs. 2013 Jan-Mar;33(1):38-42; quiz 43-4. doi: 10.1097/PSN.0b013e31828425db. PubMed 23446508 ↗
  • Durai R, Ng PC. How to insert a perfect chest drain. Acta Chir Belg. 2009 Oct;109(5):652-4. doi: 10.1080/00015458.2009.11680510. PubMed 19994817 ↗
  • Janis JE, Khansa L, Khansa I. Strategies for Postoperative Seroma Prevention: A Systematic Review. Plast Reconstr Surg. 2016 Jul;138(1):240-252. doi: 10.1097/PRS.0000000000002245. PubMed 27348657 ↗
  • Kuroi K, Shimozuma K, Taguchi T, Imai H, Yamashiro H, Ohsumi S, Saito S. Evidence-based risk factors for seroma formation in breast surgery. Jpn J Clin Oncol. 2006 Apr;36(4):197-206. doi: 10.1093/jjco/hyl019. PubMed 16684859 ↗
  • Lamp S. Closed-suction drain systems in the plastic surgery patient. Plast Surg Nurs. 2011 Oct-Dec;31(4):188-90. doi: 10.1097/PSN.0b013e318238d847. No abstract available. PubMed 22157612 ↗
  • Long LC. The home healthcare nurse as a patient. Home Healthc Nurse. 2013 Jan;31(1):47. doi: 10.1097/NHH.0b013e3182778da2. PubMed 23238624 ↗
  • Phillips BT, Wang ED, Mirrer J, Lanier ST, Khan SU, Dagum AB, Bui DT. Current practice among plastic surgeons of antibiotic prophylaxis and closed-suction drains in breast reconstruction: experience, evidence, and implications for postoperative care. Ann Plast Surg. 2011 May;66(5):460-5. doi: 10.1097/SAP.0b013e31820c0593. PubMed 21407050 ↗
  • Poulose BK, Shelton J, Phillips S, Moore D, Nealon W, Penson D, Beck W, Holzman MD. Epidemiology and cost of ventral hernia repair: making the case for hernia research. Hernia. 2012 Apr;16(2):179-83. doi: 10.1007/s10029-011-0879-9. Epub 2011 Sep 9. PubMed 21904861 ↗
  • Whitson BA, Richardson E, Iaizzo PA, Hess DJ. Not every bulb is a rose: a functional comparison of bulb suction devices. J Surg Res. 2009 Oct;156(2):270-3. doi: 10.1016/j.jss.2009.03.096. Epub 2009 May 8. PubMed 19691976 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 28, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04554407
Lead sponsor
SOMAVAC Medical Solutions
Responsible party
Sponsor
First posted
Sep 18, 2020
Start date
Aug 11, 2020
Primary completion
Sep 2022 (estimated)
Completion
Sep 2022 (estimated)
Last update
Sep 28, 2021

Study contacts

Martin D Fleming, MD
principal investigator · University of Tennessee

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion